Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine [8]

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 1, 2006, Pages 160-161

  Fiaccadori, Enrico ^a   Maggiore, Umberto ^a   Rotelli, Carlo ^a   Giacosa, Roberto ^a   Parenti, Elisabetta ^a   Cabassi, Aderville ^a   Ariya, Kraisith ^b   Wirote, Lausoontornsiri ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Bangkok Hospital Medical Center   (Thailand)

Author keywords

Antimalarial agents; Neurological status; Plasmapheresis

Indexed keywords

MEFLOQUINE;

ADULT; ANEMIA; ANOREXIA; BLURRED VISION; CASE REPORT; CAUCASIAN; CONFUSION; DRUG FEVER; HEMATURIA; HUMAN; HYPERTENSION; LETHARGY; LETTER; LEUKOCYTOSIS; MALARIA; MALARIA CONTROL; MALE; MUSCLE WEAKNESS; MYALGIA; PLASMAPHERESIS; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TRAVEL;

ANTIMALARIALS; FEMALE; HUMANS; MALARIA; MEFLOQUINE; MIDDLE AGED; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 30344446654     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki414     Document Type: Letter

References (6)

1. Wyler DJ. Malaria chemoprophylaxis for the traveler. N Engl J Med 1993; 329: 31-7.
2. Schwartz E, Potasman I, Rotenberg M et al. Serious adverse events of mefloquine in relation to blood level and gender. Am J Trop Med Hyg 2001; 65: 189-92.
3. Kojouri K, Vesely SK, George JN. Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndromes: Frequency, clinical features, and long-term outcomes. Ann Intern Med 2001; 135: 1047-51.
4. Palmer KJ, Holliday SM, Brogden RN. Mefloquine: A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993; 45: 430-75.
5. Orlando G, Isabella L, Atzori C et al. Blackwater fever after halofantrine. Lancet 1996; 347: 1408-9.
6. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003; 14: 1072-81.